(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DORIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DORIA

ST13

US500000079219041

Class

5

Filing

79219041

Registration

5477992

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

03/20/2026

Trademark type

Word

Nice classes

5

Filing date

05/11/2017

Registration date

05/29/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/13/2024

Last transaction

03/20/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

85

Owner location

ES

Examiner

BRADLEY, EVELYN

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Representatives

Kevin Hartley Trust Tree Legal, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productschemical-pharmaceuticals for the treatment of central nervous system diseasespsychosisanxiety and schizophrenia; pharmaceuticalsanxiolyticsantipsychotics; syringes for medical purposes sold filled with pharmaceuticals for treating psychosisanxiety and schizophrenia; vials for medical purposes sold filled with pharmaceuticals for treating psychosisanxiety and schizophrenia; cartridges sold filled with pharmaceuticals for treating schizophrenia; ampules sold filled with pharmaceuticals for the treatment of psychosisanxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceutical preparations for psychosisanxiety and schizophrenia; implantable subcutaneous and intramuscular drug delivery devices sold filled with pharmaceuticals for sustained release of medicines for treating psychosisanxiety and schizophrenia; preparations for the treatment of central nervous system diseases; preparations for the treatment of psychosisanxiety and schizophrenia; sanitary preparations for medical use; dietetic foods adapted for medical use; dietary supplements for humans; plasters for medical purposes

Publications

History of USPTO decisions and trademark events.

41 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

03/19/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

02/01/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

02/01/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/13/2025

C71T

CANCELLED SECTION 71

12/13/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/29/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/08/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/16/2018

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

09/13/2018

XXCR

GENERIC MADRID TRANSACTION CREATED

09/13/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

05/29/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/13/2018

PUBO

PUBLISHED FOR OPPOSITION

03/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/02/2018

ALIE

ASSIGNED TO LIE

01/26/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/17/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

01/16/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/16/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

01/16/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/16/2018

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/10/2018

GNFR

FINAL REFUSAL E-MAILED

01/10/2018

CNFR

FINAL REFUSAL WRITTEN

01/10/2018

RFNP

REFUSAL PROCESSED BY IB

12/01/2017

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

11/17/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/17/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/16/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/16/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/16/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/13/2017

RFRR

REFUSAL PROCESSED BY MPU

11/13/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/03/2017

CNRT

NON-FINAL ACTION WRITTEN

11/02/2017

MAFR

APPLICATION FILING RECEIPT MAILED

10/31/2017

DOCK

ASSIGNED TO EXAMINER

10/25/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2017

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

10/23/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/19/2017

Continuous trademark protection

Get notified about every new filing that threatens DORIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.